$ALOT
AstroNova, Inc.

2013 Q4 Form 10-Q Financial Statement

#000119312513466789 Filed on December 09, 2013

View on sec.gov

Income Statement

Concept 2013 Q4 2012 Q4
Revenue $18.18M $16.04M
YoY Change 13.34% -18.04%
Cost Of Revenue $10.82M $9.555M
YoY Change 13.2% -17.27%
Gross Profit $7.363M $6.484M
YoY Change 13.56% -19.05%
Gross Profit Margin 40.5% 40.43%
Selling, General & Admin $4.950M $4.386M
YoY Change 12.86% -21.12%
% of Gross Profit 67.23% 67.64%
Research & Development $1.230M $897.0K
YoY Change 37.12% -28.81%
% of Gross Profit 16.71% 13.83%
Depreciation & Amortization $310.0K $300.0K
YoY Change 3.33% -18.92%
% of Gross Profit 4.21% 4.63%
Operating Expenses $6.180M $5.283M
YoY Change 16.98% -22.65%
Operating Profit $1.183M $1.201M
YoY Change -1.5% 1.78%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$2.000K $47.00K
YoY Change -104.26% -167.14%
Pretax Income $1.181M $1.248M
YoY Change -5.37% 11.43%
Income Tax $436.0K $499.0K
% Of Pretax Income 36.92% 39.98%
Net Earnings $1.108M $1.307M
YoY Change -15.23% 63.38%
Net Earnings / Revenue 6.09% 8.15%
Basic Earnings Per Share $0.15 $0.18
Diluted Earnings Per Share $0.14 $0.18
COMMON SHARES
Basic Shares Outstanding 7.490M shares 7.379M shares
Diluted Shares Outstanding 7.716M shares 7.462M shares

Balance Sheet

Concept 2013 Q4 2012 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $32.60M $23.00M
YoY Change 41.74% 4.55%
Cash & Equivalents $12.97M $14.79M
Short-Term Investments $19.70M $8.200M
Other Short-Term Assets $12.50M $3.300M
YoY Change 278.79% -19.51%
Inventory $11.92M $14.50M
Prepaid Expenses
Receivables $10.97M $11.80M
Other Receivables $500.0K $400.0K
Total Short-Term Assets $68.58M $52.90M
YoY Change 29.65% 3.52%
LONG-TERM ASSETS
Property, Plant & Equipment $7.723M $10.70M
YoY Change -27.82% -13.71%
Goodwill $795.0K
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $100.0K $100.0K
YoY Change 0.0% 0.0%
Total Long-Term Assets $1.462M $14.00M
YoY Change -89.56% -7.28%
TOTAL ASSETS
Total Short-Term Assets $68.58M $52.90M
Total Long-Term Assets $1.462M $14.00M
Total Assets $77.77M $66.90M
YoY Change 16.25% 1.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.750M $2.200M
YoY Change 25.0% 4.76%
Accrued Expenses $6.300M $4.400M
YoY Change 43.18% 0.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $11.70M $7.500M
YoY Change 55.99% 0.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.300M $800.0K
YoY Change 62.5% -33.33%
Total Long-Term Liabilities $1.300M $800.0K
YoY Change 62.5% -33.33%
TOTAL LIABILITIES
Total Short-Term Liabilities $11.70M $7.500M
Total Long-Term Liabilities $1.300M $800.0K
Total Liabilities $13.21M $10.20M
YoY Change 29.54% -7.27%
SHAREHOLDERS EQUITY
Retained Earnings $35.88M
YoY Change
Common Stock $461.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $12.35M
YoY Change
Treasury Stock Shares 1.721M shares
Shareholders Equity $64.56M $56.80M
YoY Change
Total Liabilities & Shareholders Equity $77.77M $66.90M
YoY Change 16.25% 1.06%

Cashflow Statement

Concept 2013 Q4 2012 Q4
OPERATING ACTIVITIES
Net Income $1.108M $1.307M
YoY Change -15.23% 63.38%
Depreciation, Depletion And Amortization $310.0K $300.0K
YoY Change 3.33% -18.92%
Cash From Operating Activities $1.200M $1.920M
YoY Change -37.5% -33.56%
INVESTING ACTIVITIES
Capital Expenditures -$540.0K -$210.0K
YoY Change 157.14% -38.24%
Acquisitions
YoY Change
Other Investing Activities $580.0K $3.190M
YoY Change -81.82% -562.32%
Cash From Investing Activities $40.00K $2.980M
YoY Change -98.66% -389.32%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -450.0K -1.270M
YoY Change -64.57% 73.97%
NET CHANGE
Cash From Operating Activities 1.200M 1.920M
Cash From Investing Activities 40.00K 2.980M
Cash From Financing Activities -450.0K -1.270M
Net Change In Cash 790.0K 3.630M
YoY Change -78.24% 221.24%
FREE CASH FLOW
Cash From Operating Activities $1.200M $1.920M
Capital Expenditures -$540.0K -$210.0K
Free Cash Flow $1.740M $2.130M
YoY Change -18.31% -34.06%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14789000
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
619867 shares
CY2012Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11704000
CY2012Q1 alot Debt Received Upon Sale Of Operation
DebtReceivedUponSaleOfOperation
1000000
CY2013Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7512803 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9228305 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
113546 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.64
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
794515 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
8.59
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
13000000 shares
CY2013Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1721098 shares
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.05
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
9.11
CY2013Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
1336000
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
27045000
CY2013Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3641000
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
40429000
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2750000
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11699000
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
135000
CY2013Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
931000
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2649000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
64555000
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
35878000
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
499000
CY2013Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
21000
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
461000
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
77768000
CY2013Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
178000
CY2013Q4 us-gaap Liabilities
Liabilities
13213000
CY2013Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
2139000
CY2013Q4 us-gaap Assets Current
AssetsCurrent
68583000
CY2013Q4 us-gaap Goodwill
Goodwill
795000
CY2013Q4 us-gaap Financial Instruments Owned State And Municipal Government Obligations At Fair Value
FinancialInstrumentsOwnedStateAndMunicipalGovernmentObligationsAtFairValue
19654000
CY2013Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
19654000
CY2013Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1800000
CY2013Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
1128000
CY2013Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
569000
CY2013Q4 us-gaap Assets
Assets
77768000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12974000
CY2013Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
6383000
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10970000
CY2013Q4 us-gaap Inventory Net
InventoryNet
11916000
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
34768000
CY2013Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
5208000
CY2013Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
2514405
CY2013Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1462000
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1682000
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3185525
CY2013Q4 us-gaap Other Assets
OtherAssets
98000
CY2013Q4 us-gaap Assets Held For Sale Current
AssetsHeldForSaleCurrent
2016000
CY2013Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
250000
CY2013Q4 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
27211000
CY2013Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
1825000
CY2013Q4 us-gaap Treasury Stock Value
TreasuryStockValue
12348000
CY2013Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
4405000
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7723000
CY2013Q4 alot Money Market Funds At Fair Value
MoneyMarketFundsAtFairValue
7557000
CY2013Q4 alot Line Of Credit Receivable Current
LineOfCreditReceivableCurrent
288000
CY2013Q4 alot Revolving Line Of Credit Facility Issued Maximum Capacity
RevolvingLineOfCreditFacilityIssuedMaximumCapacity
600000
CY2013Q4 alot Revolving Line Of Credit Facility Issued Amount Outstanding
RevolvingLineOfCreditFacilityIssuedAmountOutstanding
288000
CY2013Q4 alot Product Replacement Reserve
ProductReplacementReserve
520000
CY2013Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9031756 shares
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
96900 shares
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.46
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
916612 shares
CY2013Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
13000000 shares
CY2013Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
1663214 shares
CY2013Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.05
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
8.10
CY2013Q1 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
1289000
CY2013Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
26098000
CY2013Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3164000
CY2013Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
38786000
CY2013Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1938000
CY2013Q1 us-gaap Liabilities Current
LiabilitiesCurrent
14219000
CY2013Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
173000
CY2013Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
941000
CY2013Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3176000
CY2013Q1 us-gaap Stockholders Equity
StockholdersEquity
63837000
CY2013Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
36092000
CY2013Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
271000
CY2013Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
4169000
CY2013Q1 us-gaap Common Stock Value
CommonStockValue
452000
CY2013Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
79557000
CY2013Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
212000
CY2013Q1 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
3131000
CY2013Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
1647000
CY2013Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
696000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1624000
CY2013Q1 us-gaap Other Assets
OtherAssets
96000
CY2013Q1 us-gaap Liabilities
Liabilities
15720000
CY2013Q1 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
1501000
CY2013Q1 us-gaap Assets Current
AssetsCurrent
70122000
CY2013Q1 us-gaap Goodwill
Goodwill
795000
CY2013Q1 us-gaap Financial Instruments Owned State And Municipal Government Obligations At Fair Value
FinancialInstrumentsOwnedStateAndMunicipalGovernmentObligationsAtFairValue
8509000
CY2013Q1 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
8509000
CY2013Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1800000
CY2013Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
591000
CY2013Q1 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
756000
CY2013Q1 us-gaap Assets
Assets
79557000
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30999000
CY2013Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
6654000
CY2013Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9376000
CY2013Q1 us-gaap Inventory Net
InventoryNet
11179000
CY2013Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
33886000
CY2013Q1 us-gaap Assets Held For Sale Current
AssetsHeldForSaleCurrent
2016000
CY2013Q1 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
250000
CY2013Q1 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
17293000
CY2013Q1 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
1866000
CY2013Q1 us-gaap Treasury Stock Value
TreasuryStockValue
11666000
CY2013Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3934000
CY2013Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7788000
CY2013Q1 alot Money Market Funds At Fair Value
MoneyMarketFundsAtFairValue
8784000
CY2013Q1 alot Line Of Credit Receivable Current
LineOfCreditReceivableCurrent
300000
CY2013Q1 alot Proceeds From Discontinued Operations Held In Escrow
ProceedsFromDiscontinuedOperationsHeldInEscrow
1800000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.009 pure
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.42
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.21
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7486588 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.392 pure
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
72315 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.42
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.034 pure
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3031000
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.22
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7414273 shares
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.21
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.20
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.21
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
654194 shares
us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
13520000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3056000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1354000
us-gaap Gross Profit
GrossProfit
17541000
us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
1535000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2138000
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
11816000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1559000
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
1535000
us-gaap Operating Income Loss
OperatingIncomeLoss
2194000
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
1596000
us-gaap Disposal Group Including Discontinued Operation Gross Profit Loss
DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss
6969000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-66000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
200000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-56000
us-gaap Net Income Loss
NetIncomeLoss
3131000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
359000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-75000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
770000
us-gaap Sales Revenue Net
SalesRevenueNet
45038000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
527000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-9000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
61000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1081000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3339000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2268000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
27497000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
72000
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
305000
us-gaap Share Based Compensation
ShareBasedCompensation
305000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
3085000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9242000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
174000
us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
928000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2322000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2766000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
993000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
14965000
us-gaap Operating Expenses
OperatingExpenses
15347000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
542000
alot Income Tax Expense
IncomeTaxExpense
844000
alot Income Tax Benefit Favorable Resolution Of Previously Uncertain Tax Position
IncomeTaxBenefitFavorableResolutionOfPreviouslyUncertainTaxPosition
302000
alot Line Of Credit Issuance
LineOfCreditIssuance
300000
dei Entity Registrant Name
EntityRegistrantName
ASTRO MED INC /NEW/
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2013-11-02
dei Entity Central Index Key
EntityCentralIndexKey
0000008146
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
57544 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.008 pure
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
9.53
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.21
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7650014 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.383 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
200763 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
us-gaap Nature Of Operations
NatureOfOperations
<div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> <b>(1) Overview</b></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Headquartered in West Warwick, Rhode Island, Astro-Med Inc. designs, develops, manufactures and distributes a broad range of specialty printers and data acquisition and analysis systems. Our products are distributed through our own sales force and authorized dealers in the United States. We also sell to customers outside of the United States primarily through our branch offices in Canada and Europe as well as with independent dealers and representatives. Astro-Med, Inc. products are sold under the brand names Astro-Med&#xA0;<sup style="font-size:85%; vertical-align:top">&#xAE;</sup> Test&#xA0;&amp; Measurement and QuickLabel <sup style="font-size:85%; vertical-align:top">&#xAE;</sup> Systems and are employed around the world in a wide range of aerospace, automotive, communications, chemical, food and beverage, military, industrial, and packaging applications.</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Unless otherwise indicated, references to &#x201C;Astro-Med,&#x201D; the &#x201C;Company,&#x201D; &#x201C;we,&#x201D; &#x201C;our,&#x201D; and &#x201C;us&#x201D; in this Quarterly Report on Form&#xA0;10-Q refer to Astro-Med, Inc. and its consolidated subsidiaries.</p> </div>
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y8M12D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
8.15
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
10.54
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.026 pure
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4994000
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.11
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
8.16
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
56800 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
10.14
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7449251 shares
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 Segment
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
22624 shares
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.07
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y7M6D
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
156273 shares
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.07
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.11
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
172100 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
40898 shares
us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
6201000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1317000
us-gaap Gross Profit
GrossProfit
19390000
us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
517000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1284000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4881000
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
19056000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1569000
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
517000
us-gaap Operating Income Loss
OperatingIncomeLoss
1348000
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
838000
us-gaap Disposal Group Including Discontinued Operation Gross Profit Loss
DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss
668000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-56000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3368000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-362000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-64000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
30796000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
192000
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
406000
us-gaap Share Based Compensation
ShareBasedCompensation
406000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-18025000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10680000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-4940000
us-gaap Net Income Loss
NetIncomeLoss
1355000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1039000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-38000
us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-38000
us-gaap Sales Revenue Net
SalesRevenueNet
50858000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
910000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
18000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
564000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1087000
us-gaap Other Than Temporary Impairment Losses Investments Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities
0
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3745000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1005000
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
333000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12026000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3617000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
951000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
7940000
us-gaap Operating Expenses
OperatingExpenses
18042000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
446000
alot Income Tax Expense
IncomeTaxExpense
464000
alot Agreement Expiration Date
AgreementExpirationDate
2014-01-31
alot Number Of Installments
NumberOfInstallments
16 Installment
alot Escrow Deposit Period
EscrowDepositPeriod
P12M
alot Term Of Agreement
TermOfAgreement
P2Y
alot Loan Receivable Interest Rate Stated Percentage
LoanReceivableInterestRateStatedPercentage
0.06 pure
alot Fees To Non Employee Director
FeesToNonEmployeeDirector
7000
alot Income Tax Benefit Favorable Resolution Of Previously Uncertain Tax Position
IncomeTaxBenefitFavorableResolutionOfPreviouslyUncertainTaxPosition
18000
alot Non Employee Director Received Restricted Stock Award Value
NonEmployeeDirectorReceivedRestrictedStockAwardValue
20000
alot Reservation Of Shares Under Employee Stock Purchase Plan
ReservationOfSharesUnderEmployeeStockPurchasePlan
247500 shares
CY2012Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-2000
CY2012Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1187000
alot Product Replacement Related Costs
ProductReplacementRelatedCosts
672000
alot Short Term Investment Securities Original Maturity Greater Than Ninety Days
ShortTermInvestmentSecuritiesOriginalMaturityGreaterThanNinetyDays
P90D
alot Loan Receivable Date Considered For Interest Payments
LoanReceivableDateConsideredForInterestPayments
2013-01-30
alot Effective Tax Rate Current Year
EffectiveTaxRateCurrentYear
0.347 pure
alot Effective Tax Rate Prior Year
EffectiveTaxRatePriorYear
0.254 pure
alot Maximum Disposal Restriction As Percentage Of Restricted Stock Units
MaximumDisposalRestrictionAsPercentageOfRestrictedStockUnits
0.50 pure
alot Agreement Effective Start Date
AgreementEffectiveStartDate
2014-02-01
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y4M24D
CY2013 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
18600000
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.09
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.01
CY2012Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
CY2012Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.07
CY2012Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7461958 shares
CY2012Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
82864 shares
CY2012Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.93
CY2012Q4 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.10
CY2012Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7379094 shares
CY2012Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.08
CY2012Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.08
CY2012Q4 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.10
CY2012Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
595394 shares
CY2012Q4 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
4523000
CY2012Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1490000
CY2012Q4 us-gaap Gross Profit
GrossProfit
6484000
CY2012Q4 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
558000
CY2012Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1248000
CY2012Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
558000
CY2012Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
1201000
CY2012Q4 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
749000
CY2012Q4 us-gaap Disposal Group Including Discontinued Operation Gross Profit Loss
DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss
2354000
CY2012Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
185000
CY2012Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
47000
CY2012Q4 us-gaap Net Income Loss
NetIncomeLoss
1307000
CY2012Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
183000
CY2012Q4 us-gaap Sales Revenue Net
SalesRevenueNet
16039000
CY2012Q4 us-gaap Cost Of Goods Sold
CostOfGoodsSold
9555000
CY2012Q4 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
180000
CY2012Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3199000
CY2012Q4 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
-2000
CY2012Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
897000
CY2012Q4 us-gaap Operating Expenses
OperatingExpenses
5283000
CY2012Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
499000
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.79
CY2013Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
CY2013Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.07
CY2013Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7715820 shares
CY2013Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
226130 shares
CY2013Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.00
CY2013Q4 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.10
CY2013Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7489690 shares
CY2013Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.04
CY2013Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.05
CY2013Q4 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.10
CY2013Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
131600 shares
CY2013Q4 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
2485000
CY2013Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1259000
CY2013Q4 us-gaap Gross Profit
GrossProfit
7363000
CY2013Q4 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
363000
CY2013Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1181000
CY2013Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
363000
CY2013Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
1183000
CY2013Q4 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
745000
CY2013Q4 us-gaap Disposal Group Including Discontinued Operation Gross Profit Loss
DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss
290000
CY2013Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
137000
CY2013Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2000
CY2013Q4 us-gaap Net Income Loss
NetIncomeLoss
1108000
CY2013Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
151000
CY2013Q4 us-gaap Sales Revenue Net
SalesRevenueNet
18179000
CY2013Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
14000
CY2013Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1223000
CY2013Q4 us-gaap Cost Of Goods Sold
CostOfGoodsSold
10816000
CY2013Q4 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
127000
CY2013Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3727000
CY2013Q4 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
-89000
CY2013Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1230000
CY2013Q4 us-gaap Operating Expenses
OperatingExpenses
6180000
CY2013Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
436000
CY2013Q4 alot Income Tax Benefit Favorable Resolution Of Previously Uncertain Tax Position
IncomeTaxBenefitFavorableResolutionOfPreviouslyUncertainTaxPosition
187000
CY2013Q4 alot Effective Tax Rate Current Year
EffectiveTaxRateCurrentYear
0.369 pure
CY2013Q4 alot Effective Tax Rate Prior Year
EffectiveTaxRatePriorYear
0.400 pure
CY2013Q4 alot Developments Affecting Unrecognized Tax Benefits
DevelopmentsAffectingUnrecognizedTaxBenefits
0
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.79

Files In Submission

Name View Source Status
0001193125-13-466789-index-headers.html Edgar Link pending
0001193125-13-466789-index.html Edgar Link pending
0001193125-13-466789.txt Edgar Link pending
0001193125-13-466789-xbrl.zip Edgar Link pending
alot-20131102.xml Edgar Link completed
alot-20131102.xsd Edgar Link pending
alot-20131102_cal.xml Edgar Link unprocessable
alot-20131102_def.xml Edgar Link unprocessable
alot-20131102_lab.xml Edgar Link unprocessable
alot-20131102_pre.xml Edgar Link unprocessable
d607296d10q.htm Edgar Link pending
d607296dex311.htm Edgar Link pending
d607296dex312.htm Edgar Link pending
d607296dex321.htm Edgar Link pending
d607296dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending